Augment Biologics

Glycosylation, the attachment of sugar molecules to proteins, is a complex but critical process in drug development, as its variability can significantly affect the safety, efficacy, and stability of therapeutic proteins, making precise and consistent control a manufacturing challenge. Augment Biologics is a platform-e

Augment Biologics is a business in ai machine learning based in San Francisco Ca United States, founded in 2021.

Profile

Glycosylation, the attachment of sugar molecules to proteins, is a complex but critical process in drug development, as its variability can significantly affect the safety, efficacy, and stability of therapeutic proteins, making precise and consistent control a manufacturing challenge. Augment Biologics is a platform-enabled therapeutics company with a proprietary glycoengineering platform, GlycoTemplating, that genetically encodes […]

The company sits in the ai machine learning segment, where it competes on its core product or service.

The company is recorded as being based in San Francisco Ca United States.

It is recorded at the SOSV portfolio company stage.

Its team size is recorded as 2-10 employees.

Website: augmentbiologics.com